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Glycocyamine is formed in the kidney by the transfer of the 
amidine group of arginine to the nitrogen atom of glycine. In the 
study of this reaction it was observed that glycocyamine was also 
formed from citrulline and glycine. No other donor or precursor of 
the amidine group was found (1). 
The most probable explanation of this effect of citrulline was that 
it was first converted to arginine, from which the amidine group was 
then transferred to glycine. This has now been proved. 
This formation of arginine consists in an interaction of citrulline 
with either glutamic acid or aspartic acid. Its speed is of the same 
order of magnitude as that of oxidative deamination in the kidney. 
The two dicarboxylicamino acids are equally effective in this 
respect. An oxidation is involved in the reaction; it is nearly com- 
pletely inhibited by such oxidation inhibitors as KCN, AsZ03, and 
As205 in low concentration. The KCN inhibition is partly relieved 
by hydrogen acceptors; that of As203 and AszOs is not. 
There are in general three possible types of mechanism for this 
reaction, the essential differences in them consisting in the point at 
which the oxidation, i.e. the dehydrogenation, occurs: (a) at the 
dicarboxylicamino acid before it reacts with the citrulline, (b) at an 
intermediate compound consisting of the citrulline and the di- 
carboxylicamino acid, or (c), after the cleavage of this hypotheti- 
cal intermediate compound, at a derivative of the citrulline which is 
the immediate precursor of the arginine. 
* Aided by a grant from Mr. I. Zellerbach. 
A summary of this work has appeared (Proc. Am. Sot. Biol. Chem., 
J. Biol. Chem., 140, p. xviii (1941)). 
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The first of the three possibilities is depicted by the following 
equat’ions, 
(1, a) COOH. .:-COOH + oxidized hydrogen acceptor + 
I 
NH2 
(Aspartic acid or 
glutamic acid) 
COOH. C-COOH + reduced hydrogen acceptor 
II 
NH 
(Dicarboxylicimino 
acid) 
(1, b) COOH. .C-COOH + NH2C-NH.. .COOH --3 
II 
NH 
(Citrulline) 
COOH. .C-COOH* + NHX-C. COOH 
(a-Kctodicarboxylic acid) (Arginine) 
* Here, as in Equations 2 to 4, the dicarboxylic acid is written as being 
converted to the corresponding keto acid derivative. This is done only 
for convenience. We have obtained no evidence regarding the nature of 
the product arising from the deaminized dicarboxylicamino acid. It is 
possible that it is also decarboxylated in the oxidation; i.e., the reaction 
mechanism is that suggested by Herbst (2). 
This mechanism was eliminated by the finding that arginine 
formation is inhibited under conditions in which oxidative deami- 
nation of the dicarboxylicamino acids proceeds unchecked. 
Arginine is also formed from citrulline, ammonia, and a-keto- 
glutarate or oxalacetate. These reactions are also inhibited by 
KCN or Asz03. The interpretation we have placed on these re- 
sults is that here also the reaction proper (i.e., arginine formation) 
is between citrulline and glutamic acid or aspartic acid; that the 
dicarboxylicamino acids were formed by reductive amination prior 
to their combination with citrulline. It follows that the imino 
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acid derivatives of the dicarboxylicamino acids (which are formed 
spontaneously and are in equilibrium in water with their corre- 
sponding ar-keto acids and ammonia) do not react with the ci- 
trulline. This evidence also therefore excludes the reaction mech- 
anism of Equations 1, a and 1, b. 
The other two possible mechanisms are given by Equations 
2, 3, and 4. 
P 
(2, a) COOH.. .C-COOH + COOH.. .NH-C-NH2 
I II 
NJ& 0 
H 
(2, b) 
(2, c) 
I 
* COOH. C-COOII 
I 
NH 
H 1 
COOH. . N-C-NH2 
I 
OH 
OH 
I 
-G COOH. C-COOH 
I 
NH 
H I 
COOH. N-CfI-NH2 
(3, a) 
OH 
I 
COOII. C-COOII + oxidized hydrogen acceptor 
tiH 
I 
COOH. . .NH-CH-NH2 
(3, b) + COOH. .C-COOH + COOH. NI-I-C-NHn + 
II II 
0 NH 
reduced hydrogen accept,or 
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01 
OH 
I 
(4, a) COOH. C-COOH -+ 
NH 
I 
COOH. NH-CH-NH2 
NIL 
(4, b) COOH. .C-COOH + COOH.. . .NH-CH-NH2 
II 
0 
(4, c) COOH. NH-CH-NH2 + oxidized hydrogen acceptor -+ 
(4, d COOH. .NH-C-NH2 + reduced hydrogen acceptor 
II 
NH 
In both mechanisms an intermediate compound between the 
citrulline and the dicarboxylic acid is postulated. According to 
the mechanism of Equations 3, a and 3, b this compound is de- 
composed by dehydrogenation into arginine and the a-keto acid 
derivative of the dicarboxylicamino acid. 
In the mechanism of Equations 4, a to 4, d the hypothetical in- 
termediate compound is decomposed first and the resulting diamine 
group undergoes dehydrogenation to form arginine. 
If the mechanism of Equations 4, a to 4, d were correct, when 
citrulline and the dicarboxylicamino acid are present but arginine 
formation is prevented by AsZOs, the keto acid should be formed 
nevertheless, but without an equivalent amount of ammonia. Am- 
monia and keto acid will be formed in addition from the concurrent 
and independent oxidative deamination of the dicarboxylicamino 
acid. Accordingly the ratio A NH3 to A keto acid should be lower 
and the absolute amount of keto acid higher in solutions containing 
citrulline, dicarboxylicamino acid, and As203 than in the absence of 
citrulline; i.e., the reaction would proceed as far as Equation 4, b. 
It was found that the ratio A NH8 to A keto acid in the presence of 
As203 was the same with and without citrulline; nor was there an 
absolute increase in keto acid in the presence of citrulline. 
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The evidence appears to lead by exclusion to a mechanism of the 
type of Equations 2 and 3. Braunstein (3) postulated an inter- 
mediate compound analogous to that of Equation 2 as a prelimi- 
nary to transamination. It must be emphasized that in both cases 
the existence of this hypothetical compound is, as yet, unsupported 
by any direct evidence. It is an inference only. 
Positive results were obtained when proline, hydroxyproline, 
ornithine, or lysine was used in place of aspartic acid or glutamic 
acid. All the other amino acids were negative. There is inde- 
pendent evidence that the first three amino acids named are 
readily convertible to glutamic acid in the rat (4-7). It is rea- 
sonable to conclude, therefore, that lysine also is converted to glu- 
tamic acid (or aspartic acid). This is the first clue, as far as we are 
aware, regarding the path of degradation of the carbon skeleton of 
lysine in the animal body. 
In the ornithine cycle by which urea is formed in the liver from 
ammonia and carbon dioxide, one of the steps proposed is the con- 
version of citrulline to arginine (8). The mechanism for this con- 
version which we have found in kidney, i.e. the interaction of 
citrulline with aspartic acid or glutamic acid, does not occur in 
liver. A study of arginine formation in liver is in progress and will 
be reported later. 
Procedure and Preparations Used 
Most of the experiments were carried out with surviving rat kid- 
ney slices. In a few experiments guinea pig kidney was used. ,The 
details of the technique have been described (9). Two or three 
small slices were suspended in 4 ml. of bicarbonate-Ringer’s solu- 
tion containing the substances under investigation. Trhe pH of 
the solution was 7.4 after equilibration with 95 per cent oxygen and 
5 per cent COz. All the experiments were carried out at 38” for 1 
or 2 hours. 
At the end of the experimental period the contents of the reac- 
tion vessels, acidified to pH 6.0 with a drop of 0.5 N HCl, the slices, 
and two 2.5 ml. washings with water were transferred to test-tubes 
graduated at 10 ml. After 10 minutes in a boiling water bath the 
test-tubes were cooled, and the contents made up to the mark with 
water, mixed by shaking, and filtered. The tissue slices were dried 
at 100” and weighed. 
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Glycocyamine and arginine were then determined in the pro- 
tein-free filtrates. A 5 ml. aliquot was passed through a column of 
permutit and the traces of glycocyamine remaining in the column 
removed with 5 ml. of 0.3 per cent NaCl. The glycocyamine was 
determined in the combined filtrate by the method we have de- 
scribed (10). The arginine was then eluted from the permutit and 
determined as described by Dubnoff.’ 
Ammonia and keto acids were also determined in some ex- 
periments. These analyses were carried out on the protein-free 
filtrates which were not passed through permutit. The analyti- 
cal method used for ammonia has been described (11). 
The keto acids were determined as follows: To 2 ml. of protein- 
free filtrate 0.3 ml. of a saturated solution of 2,4-dinitrophenyl- 
hydrazine in 1 N HCl was added, followed after standing for a few 
minutes by 1 ml. of 1 per cent NaOH. An intense, deep red color 
appears immediately. This quickly fades and after 20 minutes a 
stable red color remains whose intensity is proportional to the con- 
centration of pyruvic acid, oxalacetic acid, or a-ketoglutaric acid 
present. A linear relationship is obtained between the concentra- 
tion of keto acid and the depth of color when it is measured at a 
wave-length of 0.525 p, in the concentration range from 0 to 2.0 
mg. per cent. The color of higher concentrations is too deep to be 
measured accurately. 
The use of 2,4-dinitrophcnylhydrazine in alkaline solution for 
the colorimctric determination of pyruvic and other keto acids has 
recently been reviewed by Klein (12). The simple procedure we 
have employed, without preliminary extraction of the hydrazone, 
would give positive values with such substances as acetone and 
acetoacetic acid. Under our experimental conditions the latter two 
substances arc not formed in measurable amounts. The controls 
(Table VII) showed that for our limited purposes the simplified pro- 
cedure was satisfactory. 
Z(+)-Citrulline was used throughout. It was prepared by a 
combination of the methods described by Kurtz (13) and by Gornall 
and Hunter (14). The starting material was a commercial prepara- 
tion of Z(+)-ornithine. All the other amino acids used were pre- 
pared or purified either by Amino Acid Manufactures, University 
of California at Los Angeles, or in this laboratory. We are in- 
1 Dubnoff, J. W., J. Biol. Chem., 141, 711 (1941). 
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debted to Professor H. B. Vickery for a generous donation of glu- 
tamine. The naturally occurring isomers of the amino acids were 
used except when the dl form is specified. 
Pyruvic acid was prepared by distillation of a commercial prod- 
uct; the distillate was neutralized by NaOH, and the sodium salt 
crystallized and dried. 
a-Ketoglutaric acid was prepared by the method of Neuberg and 
Ringer (15). We are indebted to Mr. Werner Baumgarten for this 
preparation. 
Oxalacetic acid was prepared by the method of Simon (16). 
The cY-keto acid derivative of methionine was obtained by oxida- 
tion of dl-methionine with d-amino acid oxidase prepared from hog 
kidney, ethereal extraction of the acid from the acidified, depro- 
teinized solution, evaporation of the ether, solution of the acid in 
water, neutralization with NaOH, and recrystallization from water. 
The acetaldehyde was a commercial preparation. 
Coenzyme I was prepared by the method of Ohlmeyer (17), and 
coenzyme II and adenosine triphosphate according to the pre- 
scription given by Warburg and Christian (18). The coenzyme 
preparations, as used, were 60 per cent pure. These preparations 
were made by Dr. Norman H. Horowitz. 
Results 
Table I is a typical protocol showing the formation of arginine 
from citrulline and glutamic acid or aspartic acid. There was al- 
ways a significant increase in arginine over the blank value when 
citrulline alone was added to the Ringer’s solution. This arginine 
was formed, presumably, from the added citrulline and aspartic 
acid or glutamic acid (see Table IV) which was present in the kid- 
ney slices at the outset or formed in the slices during the experi- 
ment. Nearly 3 times as much arginine was formed, however, 
when either aspartic acid or glutamic acid was added with the cit- 
rulline. The two dicarboxylicamino acids were equally effec- 
tive. 
There was a small increase in glycocyamine whenever arginine 
formation occurred. It may be inferred from previous observa- 
tions (1) that the amidine group of the arginine was transferred to 
glycine which was present in the slices initially or formed in the 
course of the experiment. The quantity of available glycine was 
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small and also limited because no more glycocyamine was formed 
when the arginine was increased 3-fold. 
It was not feasible, because of the high solubility of arginine and 
its salts, to attempt to prove by isolating one of them that the sub- 
stance we were measuring calorimetrically was arginine. This was 
TABLE I 
Typical Protocol Showing Formation of Arginine by Surviving Rat Kidney 
Slices from Citrulline and Glutamic Acid OT Aspurtic Acid 
Ringer’s solution; 38”; 1 hour. 
sO1k:.o*’ 
(1) 
1 3.2 - - 
2 7.3 - - 
3 7.2 + - 
4 6.7 + - 
5 11.7 - + 
6 11.1 - + 
7 8.3 + + 
8 6.2 + + 
9 10.3 - - 
10 11.9 - - 
11 6.1 + - 
12 7.5 + - 
Tissue 
weight, 
dry 
(2) 
ml. 
C 
( 
.- 
itrulline 
I.0025 M 
(3) 
I ( Xutamic acid, 
0.005 M 
(4) 
i 2sp$ie 
0.005 6 
(5) 
- 
- 
- 
- 
- 
- 
- 
- 
+ 
+ 
+ 
+ 
Arginine found 
(6) 
mg.  
1er cent 9 
0.02 
0.02 
0.33 
0.31 
0.04 
0.04 
1.07 
0.89 
0.03 
0.04 
0.89 
1.02 
(7) - 
mg. per 
m  fresh 
tissue 
0.3 
0.1 
1.8 
1.9 
0.1 
0.1 
5.2 
5.7 
0.1 
0.1 
5.8 
5.4 
(8) 
0.02 
0.04 
0.07 
0.07 
0.04 
0.06 
0.08 
0.07 
0.04 
0.04 
0.06 
0.07 
- 
1 
QT 
(9) 
ng. pw 
n. fresh 
tissue 
0.3 
0.2 
0.4 
0.4 
0.1 
0.2 
0.4 
0.4 
0.2 
0.2 
0.4 
0.4 
The figures in Columns 6 and 8 give the concentrations of argini’ne and 
of glycocyamine in the protein-free solutions after they had passed through 
the columns of permutit. The figures in Columns 7 and 9 are obtained 
by multiplying those in Columns 6 and 8 respectively by the factors, 4/100 X 
10/4 x 2 x 1000/(5 x IV) = 40/W, where W is the dry weight of tissue in 
mg. The basis of these factors is as follows: The volume of the original, 
undiluted Ringer’s solution was 4 ml.; it was diluted to 10 ml. for depro- 
teinization; in the course of separation of the glycocyamine and elution 
from permutit the aliquot used was diluted with an equal volume of salt 
solution; the fresh weight of the slices is 5 times the dry weight. 
established by three independent pieces of evidence: the speci- 
ficity of the color reagent under the conditions in which we used it, 
the disappearance of this chromogenic material when subjected to 
the action of arginase, and the formation of glycocyamine in the 
highly specific transamidination reaction with glycine. 
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The color reagent, the Sakaguchi reagent, gives a positive test 
with only three common biological substances. These are glyco- 
cyamine, histidine, and arginine. Glycocyamine is separated 
quantitatively from arginine and histidine by the adsorption and 
elution procedure employed. Histidine, however, remains on the 
permutit and is removed with arginine by the 3 per cent sodium 
chloride solution used for eluting the arginine from permutit. His- 
tidine has about 1 per cent the chromogenic power of arginine. 
Even if all the added citrulline had been converted to histidine, 
most of the color developed would still remain to be accounted for. 
Table II presents direct evidence that the material in question 
was arginine. Digestion with arginase removed nearly all of the 
chromogenic material designated as arginine. The details of the 
experimental procedure are given in the foot-note to Table II. 
The transamidination reaction (i.e., formation of glycocyamine 
from arginine and glycine) is a highly specific test for arginine when 
an extract of kidney (instead of kidney slices) is used to provide the 
enzyme. The arginine formed from any citrulline present is 
negligible for the purposes of this test. The test consists in in- 
cubating the material in question with an excess of glycine in the 
presence of the enzyme. A positive result is indicated by the for- 
mation of glycocyamine, and the rate of formation of glycocyamine 
is proportional to the initial concentration of arginine. 
Table III shows that this criterion also afforded clear evidence 
that we were dealing with arginine. If the chromogenic sub- 
stance in experiments such as those in Table I was arginine, it was 
to be expected that there would be (a) little or no glycocyamine in 
Solutions 1, 3, and 4 of Table III, (b) large increases in Solutions 
2, 5, and 6, with 2 to 3 times as much in Solutions 5 and 6 as in 
Solution 2, and (c) less arginine remaining in this experiment than 
in the experiment of Table I because of the conversion of some of 
the arginine to glycocyamine; the “total”2 arginine formed per 
hour would, however, be the same in Solutions 5 and 6 of Table 
III as in Solutions 7 and 8 and 11 and 12 of Table I. The results 
obtained were in complete accord with these predictions. 
Table IV summarizes our findings on the relative effectiveness of 
2 The “total” arginine is the sum of the arginine found and of the amount 
of glycocyamine multiplied by 1.49 (the ratio of the molecular weight of 
arginine to that of glycocyamine). 
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different amino acids and of some other nitrogen compounds as 
contributors of the =NH group in the conversion of citrulline to 
arginine. Glutamine was the only compound which was as effec- 
tive as aspartic acid or glutamic acid. This may be taken to indi- 
cate the rapid hydrolysis of the added glutamine rather than that 
the amide itself is effective. An active glutaminase is present in 
TABLE II 
Proof from Action of Arginase That Arginine Was Main Chromogen Measured 
by Calorimetric Method Employed 
The arginine values arc measured in mg. per gm. of fresh tissue. 
- 
+ 
+ 
+ 
- 
- 
- 
+ 
- 
+ 
- 
Glutamio acid, 
0.005 M 
- 
+ 
- 
+ 
Arginino present measured 
calorimetrically 
Before action of After action of 
arginsse srginese 
1.4 0.2 
3.3 0.2 
11.0 0.6 
8.8 0.5 
1.2 0.2 
1.0 0.2 
Ringer’s solution, 38”; 1.5 hours. Each of the six mixtures was carried 
through in quadruplicate to the end of the period of incubation with kidney 
slices; pairs of similar solutions were then combined. Each of the values 
given above therefore is an average of two completely separate but identical 
experiments run simultaneously from the initial incubation with kidney 
slices through the digestion with arginase to the final calorimetric deter- 
mination. The arginine was determined before and after digestion of 
the protein-free filtrates with arginase. Dry arginase powder was prepared 
by the method of Hunter and Dauphinee (19). 4 ml. of the protein-free 
filtrate were digested at pH 8.7 for 1 hour at 38” with 0.2 ml. of a 3 per cent 
solution of the arginase powder. At the end of the hour the solutions were 
acidified to pH 6.0, boiled, and filtered. The arginine in the filtrates was 
then determined in the usual manner after removal of the glycocyamine 
with permutit. 
kidney (20). Asparagine was much less active than aspartic acid 
(the asparaginase activity of kidney is very low), while acetamide, 
formamide, and nicotinamide were negative. 
The positive results with proline, hydroxyproline, and ornithine 
were t,o be expected. Weil-Malherbe and Krebs (4) and Neber 
(5) have proved that proline and hydroxyproline are converted to 
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glutamic acid by rat kidney slices. The figures in Table IV show 
that the formation of arginine from citrulline was approximately 
twice as fast with prolinc as with hydroxyproline. This is in 
accord with the findings of Weil-Malherbe and Krebs that glu- 
tamic acid is formed twice as quickly from proline as from hy- 
droxyproline. 
The conversion of I(+)-ornithine to glutamic acid was first sug- 
gested by Krebs (6) on the basis of indirect evidence. d(+)- 
Proline and d(-)-ornithine gave the same oxidation product, 
a-keto-6-aminovalerianic acid, after treatment with d-amino 
TABLE III 
Glycine Transamidination with Arginine Formed jrom Citrulline 
The results are expressed as mg. per gm. of fresh tissue. 
I Metabolites used 
Citrulline 
Aspartic acid 
Glutamic “ 
Citrulline + aspartic acid 
“ + glutamic ” 
Glyco- 
cyamine 
0 
1.2 
0.2 
0.2 
2.6 
2.7 
Arginine “Total” srginine 
0.4 0.4 
2.0 3.8 
0.8 1.1 
0.6 0.9 
5.9 9.8 
6.6 10.6 
The different mixtures of metabolites were first incubated at 38” with 
rat kidney slices for 2 hours. The citrulline, aspartic acid, and glutamic 
acid were initially 0.01 M. A 3 ml. aliquot of each mixture was then re- 
moved and added to 1 ml. of a cell-free extract of rat kidney to which 
glycine had been added to a concentration of 0.04 M. These mixtures were 
then incubated at 38” with shaking for 6 hours. They were then depro- 
teinized and analyzed for glycocyamine and arginine. 
acid oxidase. I(-)-Proline was proved to be converted to glu- 
tamic acid. It was a reasonable surmise then that glutamic acid 
was formed also from I(+)-ornithine via cr-keto-b-aminovaleri- 
anic acid in the same manner; viz., oxidation at the b-carbon atom 
to form the acid and amination of the a-carbon atom. Direct 
evidence of this conversion was obtained by Roloff, Ratner, and 
Schoenheimer (7). These workers fed deutero ornithine to normal 
adult mice and later found not only deutero arginine but also 
deutero proline and deutero glutamic acid. Data such as those in 
Table IV reveal that the conversion of I(+)-ornithine to glutamic 
acid occurs rapidly in rat, kidney. 
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In view of the findings with proline, hydroxyproline, and orni- 
thine it is a reasonable interpretation of the positive result with 
lysine (Table IV) that this amino acid also is converted to glu- 
tamic acid.3 
TABLE IV 
Relative Efectiveness of Di$erent Amino Acids and Other Nitrogen 
Compounds As Contributors of =NH Group in Conversion of 
Citrulline to Arginine 
Ringer’s solution; 38”; 1 hour. The citrulline was initially 0.0025 M; 
all other compounds 0.005 M. Except where the dl form is specified, the 
naturally occurring isomer was used. 
The results are expressed as per cent of “total” arginine formed from 
citrulline and glutamic acid. “Total” arginine = arginine + glycocyamine 
x 1.49. 
1 
Substance 
telative speed 
of arginine 
formation 
Acetamide -7 
Alanine -8 
Ammonia 1 
Asparagine 55 
Aspartic acid 108 
Cysteine -4 
Formamide -13 
Glutamic acid 100 
Glutamine 101 
Glutathione 46 
Glycine 1 
Histidine 0 
Hydroxyproline 23 
Substance 
Relative 
speed of 
arginine 
formation 
dl-Isoleucine -8 
Lcucine -8 
Lysine 47 
dl-Methionine -8 
Nicotinic acid amide -21 
dl-Norleucine -18 
Ornithine 42 
dl-Phenylalanine -12 
Proline 51 
dl-Serine -3 
Threonine -14 
Tryptophane -16 
Tyrosine -6 
Valine 5 
Table V shows the inhibition of the interaction of citrulline and 
aspartic acid or glutamic acid by low concentrations of KCN, 
AsZ03, or AszOs. This inhibition is about 95 per cent complete. 
3 It may be expected from their structural similarity that the conversion 
of lysine to glutamic acid follows a course analogous to that of ornithine. 
One pathway for which there is some experimental evidence is as follows: 
oxidative deamination of the a-amino group, followed by oxidative de- 
amination of the s-amino group, p oxidation at the carbon atom to form 
cr-ketoglutaric acid, which is reduced with the addition of ammonia to 
glutamic acid. 
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The cyanide inhibition is relieved to a considerable extent by 
the oc-keto acid derivative of methionine, by oxalacetate, and by 
TABLE V 
Inhibition of Arginine Formation by Oxidation Inhibitors 
Ringer’s solution; 38”; 2 hours. The initial concentration of citrulline 
was 0.0025 M; of =NH donor 0.005 M. 
The results are expressed as mg. of “total” arginine per gm. of fresh 
tissue. 
Unin- KCN Ass03 AsrOs 
hibited 0.001 hI 0.001 .v 0.0036 M 
No amino acids added.. 1.3 0.9 0.9 0,s 
Citrulline......................... 2.7 1.1 1.1 1.1 
“ + aspartic acid.. . 12.2 1.8 1.8 1.7 
L‘ + glutamic “ 11.2 1.7 1.8 1.7 
TABLE VI 
Counteraction of Hydrogen Acceptors on Inhibition of Arginine Formation 
by KCN and Asz03 
Ringer’s solution; 38”; 2 hours. The citrulline was initially 0.0025 M; 
=NH donor and other metabolites 0.005 M 
=NH donor 
No amino acids added 
Citrulline alone. 
I‘ + =NH donor. 
“ + “ L‘ + 
acetaldehyde. 
Citrulline + =NH donor + 
oc-kcto acid derivative of methi- 
onine..................... 
Citrulline + =NH donor + oxal- 
acetate......................... 
Citrulline + =NH donor + pyru- 
h 
T- 
Aspartic acid i 
vate............................ 7.2 
,001 1L1 
KCN 
0.9 
1.0 
1.6 
0.9 
5.5 
3.1 
3.1 
0 1.001 Y 
As203 
0.9 
1.1 
1.0 
1.1 
1.2 6.7 
- 
i 
Glutamic acid 
Unin- ( 
libitcc 1 
1.1 
3.1 
12.0 
j.001 Y a 
KCN 
0.9 
1.0 
1.3 
0.6 
7.0 
4.3 
2.2 
0.9 
1.0 
1.6 
1.9 
1.3 
pyruvate. These metabolites do not relieve the inhibition by 
arsenite (Table VI). 
Our interpretation of these findings is that both cyanide and 
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AsSO (and AszO6) inhibit the formation of arginine by preventing 
the necessary dehydrogenation of the citrulline-aspartic acid (or 
glutamic acid) complex. The effect of cyanide is indirect; it pre- 
vents the oxidation of cytochrome. The flow of electron and of 
hydrogen transfer is thus blocked by the lack of an available ac- 
ceptor. Arginine formation can be reinstituted, however, by the 
provision of electron and hydrogen acceptors other than the cyto- 
chrome-oxygen system which can function even in the presence of 
cyanide. They must be provided in sufficient concentration be- 
cause their reoxidation is also blocked by cyanide and they cannot 
therefore function in a cyclic manner. The Lu-keto acid derivative 
of methionine, oxalacetic acid, and pyruvic acid served this pur- 
pose. Acetaldehyde did not relieve the cyanide inhibition. This 
would exclude complex formation with the cyanide as an explana- 
tion of the positive results with the above keto acids. 
The arsenite inhibition, on the other hand, is not relieved by 
these metabolites because this inhibitor interferes with the process 
of dehydrogenation; i.e., the initial process of donation of electrons 
and hydrogens is blocked. Hence the provision of additional 
hydrogen acceptors affords no relief. 
In view of the participation of the pyridine coenzymes in the 
oxidative deamination of I(+)-glutamic acid (21) and the evidence 
that an oxidation of aspartic acid or glutamic acid is involved in 
this formation of arginine, we tested the effect of coenzymes I and 
II and of adenylic acid pyrophosphate on the reaction. These sub- 
stances neither relieved the arsenite inhibition nor increased the 
rate in the absence of an oxidative inhibitor. 
The enzymatic activity of kidney slices is largely lost (about 90 
per cent) when the kidney is homogenized into a cell-free suspen- 
sion. One possible explanation for this loss of activity was that 
the pyridine coenzymes were dissociated from the protein of the 
enzyme as a result of the dilution consequent on the preparation of 
the cell-free suspension. If this explanation were correct, addition 
of one of the two pyridine coenzymes or of adenylic acid pyro- 
phosphate might be expected to restore some of the lost enzymatic 
activity. This was not the case. It is possible that some other 
coenzyme is operative in this reaction. 
Another piece of evidence against the above explanation of the 
loss of enzymatic activity is that kidney tissue homogenized and 
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tested without any added fluid is no more active than when homo- 
genized and suspended in 4 times its volume of buffer solution. 
Table VII shows the separation of oxidative deamination of the 
dicarboxylicamino acids from the process in which citrulline is con- 
verted to arginine. The latter reaction is inhibited by arsenite; 
the former is not. In fact an inhibitor such as As203 which re- 
tards the disappearance of the products of deamination, the am- 
monia and keto acids, is necessary for the demonstration of oxida- 
tive deamination by tissue slices. 
TABLE VII 
Separation of Conversion of Citrulline to Arginine from Oxidative 
Deamination 
Guinea pig kidney slices were used; Ringer’s solution; 38”; 2 hours. 
The citrulline was initially 0.0025 M; aspartic acid either 0.005 or 0.05 M 
as indicated; Asz03 0.001 M. 
The results are expressed as micromoles per gm. of fresh tissue. 
Citrulline 
- 
- 
+ 
: 
+ 
+ 
+ 
- 
- 
- 
- 
B 
Asprtrtic 
vzid, initial 
molality 
0.005 
0.05 
0.005 
0.05 
0.005 
0.05 
0.005 
0.05 
Ast0~ 
- 0.9 0 4.3 
+ 1.0 0 10.4 
- 1.9 0 7.1 
+ 0.9 0 10.9 
- 12.1 0 8.7 
- 6.3 1.8 13.6 
+ 1.7 13.5 25.5 
+ 1.3 36.9 54.2 
- 1.0 0 9.0 
- 1.2 0 20.2 
+ 1.0 10.4 23.7 
+ 1.0 35.1 54.1 
- 
4mmonia A ammonia 
pyruvic acid 
1.6 
1.4 
1.9 
1.4 
Another piece of evidence which indicated that the two oxida- 
tive processes, arginine formation and deamination, are different, 
although they involve the same substrate (aspartic acid or glu- 
tamic acid), was obtained from a comparison of the effects of two 
different concentrations of aspartic acid, 0.005 and 0.05 M. The 
higher concentration of aspartic acid inhibit,ed arginine formation, 
but the rate of deamination, in an absolute sense, was more than 3 
times greater. If the reaction consisted in an exchange of the 
oxygen on the r-carbon atom of citrulline for the =NH group of 
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the imino acid derivative of aspartic or glutamic acid, the reaction 
should proceed with oxalacetic acid and ammonia or ketoglutaric 
acid and ammonia, even in the presence of cyanide, because the 
imino acids are formed spontaneously from the latter keto acids 
and ammonia. 
Table VIII shows that arginine is formed from citrulline and the 
products of deamination of the dicarboxylicamino acids under 
normal conditions; but the reaction is completely inhibited by 
cyanide. 
TABLE VIII 
Aspartic Acid or Glutamic Acid Formation in Rat Kidney Slices; Attested to 
by Formation of Arginine from Citrulline 
Ringer’s solution; 38”; 2 hours. The initial concentration of citrulline 
was 0.0025 M; of glutamic acid or other metabolites and ammonia 0.005 M. 
The results are expressed as “tot,al” arginine formed per gm. of fresh 
tissue. 
Metabolites in addition to citrulline 
None ......................... 
Citrate + ammonia., ....... 
Fumarate + ” .......... 
Glucose + ‘I ........... 
Glutamate ..................... 
ru-Ketoglutarate + ammonia ... 
Oxalacetate + ammonia ....... 
Pyruvate + ammonia ......... 
Succinate + ” ....... 
“Total” arginine 
found 
2.4 
2.9 
4.8 
3.7 
10.5 
7.9 
4.8 
2.6 
4.5 
Three independent lines of evidence concur, therefore, in ex- 
cluding prior oxidative deamination of the aspartic acid or glutamic 
acid as part of the reaction mechanism in the formation of arginine 
from citrulline. 
As stated above, another possible reaction mechanism would 
locate the oxidation on a derivative of the citrulline after it had 
undergone transamination with the dicarboxylic acid to form a 
compound of the type 
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Dehydrogenation of the diamine group would then yield arginine. 
If this were the reaction mechanism, the addition of citrulline in the 
presence of As203 and aspartic acid or glutamic acid would, as dis- 
cussed above, decrease the ratio A ammonia to A keto acid, be- 
cause of an absolute increase in the keto acids without a corre- 
sponding increase in ammonia. The data in Table VII eliminate 
this hypothesis. In the presence of As203 the absolute amount of 
keto acids and the ratio of A ammonia to A keto acid were the same 
in the presence as in the absence of citrulline. 
The evidence, by exclusion, therefore points to the locus of the 
oxidation on a hypothetical intermediate compound of citrulline 
and the dicarboxylicamino acid. 
The reason that the ratio A ammonia to A pyruvic acid is greater 
than 1 is that As203 does not completely inhibit the oxidation of 
keto acids. Even in unpoisoned tissue the removal of ammonia is 
less complete than that of the keto acids. Similar observations 
were made by Krebs (6). 
The formation of arginine from citrulline by surviving kidney 
slices can be used as a test for potential sources of aspartic acid or 
glutamic acid. It was shown by this method that certain amino 
acids are converted in the kidney to one or the other of these two 
dicarboxylicamino acids (Table IV). The action of tissue slices in 
this respect parallels closely that of the whole animal. This paral- 
lel was also seen in the synthesis of hippuric acid (22) and of crea- 
tine (23). The same method can be used as a test for precursors 
of the carbon skeleton of the dicarboxylicamino acids. The Se- 
agents are citrulline, an excess of ammonia, and the metabolite 
in question. Some examples are shown in Table VIII. Fumarate, 
glucose, cr-ketoglutarate, oxalacetate, and succinate were definitely 
positive. A dubiously slight positive result was obtained with 
citrate. Pyruvate was negative. 
The mechanisms by which these non-nitrogenous metabolites 
may be converted to the dicarboxylicamino acids are well known 
and need not be discussed here. The data in Table VIII are 
positive evidence that these changes occur readily in the kidney. 
The citric acid cycle appears to be quantitatively less important 
than simple oxidation of succinic acid and its derivatives. 
The formation of arginine may be used as an indicator to ascer- 
tain 6he “preferred” directions of some of the reversible processes 
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in the dynamic steady state of metabolic react,ions in kidney slices. 
This test is based on the fact that, in the presence of an excess of 
citrulline, the formation of arginine is faster the greater the concen- 
tration of aspartic acid or glutamic acid (at concentrations below 
0.005 M). The following are two examples: The amount of ar- 
ginine formed from citrulline in the presence of different amino 
acids and a-ketoglutarate is an indication of the speed of trans- 
amination in the direction of glutamic acid formation; the differ- 
ence in the amount of arginine formed from citrulline, a-keto- 
glutarate, and ammonia in the presence and in the absence of 
TABLE IX 
Transamination in Rat Kidney Slices 
Ringer’s solution; 38”; 2 hours. The initial concentration of citrulline 
was 0.0025 M; of other amino acids, keto acids, and ammonia 0.005 M. 
The results are expressed as “total” arginine formed per gm. of fresh 
tissue. 
Metabolites in addition to citrulline 
None.................................................... 2.0 
Glutamate .._...._......._......._............... 10.9 
I‘ + pyruvate.................................. 7.8 
or-Ketoglutarate......................................... 3.1 
Ammonia................................................ 2.2 
cr-Ketoglutarate + ammonia............................. 4.6 
I‘ + pyruvate + ammonia.. 1.9 
Alanine + a-ketoglutarate............................... 2.8 
dl-Alanine + a-ketoglutarate. 2.1 
Valine + cr-ketoglutarate................................ 1.6 
pyruvate indicates whether ammonia nitrogen available for amino 
acid synthesis is bound preferentially as glutamic acid or as 
alanine. 
Table IX is a summary of some experiments along these lines. 
It is seen that glutamic acid contributes its amino group to pyru- 
vate. On the other hand, amino nitrogen does not pass readily 
from I( +)-alanine, dl-alanine, and I( +)-valine to c+ketoglutarate. 
In this respect ammonia is more effective. We may infer then 
that the formation of glutamic acid from a-ketoglutarate is faster 
by reductive amination than by transamination. 
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Similarly, in the presence of ammonia, oc-ketoglutarate, and py- 
ruvate there was no evidence of the formation of any glutamic 
acid available for arginine formation; presumably the nitrogen was 
bound preferentially as alanine. 
The dynamic steady state in kidney slices appears therefore to 
include a cycle which favors the formation of glutamic acid by re- 
ductive amination, followed, if suitable keto acids are available, by 
transamination to form other amino acids with the regeneration of 
the a-ketoglutarate. 
TABLE X 
Inhibition by Pyruvate of Arginine Formation from Citrulline 
Ringer’s solution; 38”; 1 hour. The initial concentration of citrulline 
was 0.0025 M; of other amino acids and pyruvate 0.005 M. 
The results are expressed as “total” arginine formed per gm. of fresh 
tissue. 
Metabolites added in addition to citrullinc 
None. 
Aspartate. 
‘G + pyruvate.. 
Glutamate.............. 
I‘ + pyruvate. 
Lysine 
“ +pyruvate..... 
Ornithine. 
‘I + pyruvate. 
Proline. 
“ + pyruvate..... 
.............. 
.............. 
.............. 
.............. 
.............. 
.............. 
1.3 
5.6 
2.8 
4.6 
2.3 
3.3 
1.8 
3.7 
2.4 
2.8 
1.1 
The situation in kidney slices appears to be similar to that in the 
whole animal. Schoenheimer and his colleagues (24) observed 
that the most extensive exchange of normal nitrogen for Nl5 
occurred in the nitrogen of aspartic acid and glutamic acid whether 
the Nr5 was introduced as ammonia or as a single amino acid. 
The formation of arginine from citrulline was inhibited by py- 
ruvate whether the donor of the =NH group was aspartic acid, 
glut,amic acid, or a precursor of these dicarboxylicamino acids 
(Table X). This is in accord with the findings in Table IX that 
pyruvate is converted to alanine at the expense of glutamic acid. 
It is interesting that pyruvate is inhibitory under the normal cir- 
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cumstances of the experiment of Table X; yet in the presence of 
cyanide it permits arginine formation to occur, neutralizing to 
some extent the cyanide inhibition (Table VI). This latter fact 
suggests strongly that pyruvate does not inhibit the oxidation 
necessary for the formation of arginine from citrulline, that it is 
inhibitory under normal circumstances because it competes 
effectively with the citrulline for the amino group of aspartic acid 
or glutamic acid. More direct evidence is required, of course, to 
determine whether or not this hypothesis is correct. 
DISCUSSION 
The work of Braunstein and Kritzmann (3, 25), of von Euler 
et al. (21), and of Cohen (26) established by indirect but strong 
evidence the central position of the dicarboxylicamino acids in the 
continual and rapid interchange of amino nitrogen which Schoen- 
heimer and his coworkers demonstrated to occur in the body by 
direct evidence (24) .* The mechanism of this interchange in- 
volves transamination and reductive amination. 
Another mechanism is involved in the formation (in the kidney) 
of arginine from citrulline in which the dicarboxylicamino acids also 
participate. Instead of transamination, the reaction might be 
designat,ed as transimination, except that the dehydrogenation of 
the amino group of the dicarboxylicamino acid does not occur 
prior to its reaction with the citrulline but while it is in combination 
with it. 
The discovery of an extremely active mechanism for converting 
citrulline to arginine in the kidney suggests a hitherto unsuspected 
source of the arginine which the kidney requires for, among other 
purposes, the transamidination reaction with glycine to form gly- 
cocyamine. 
It seems improbable that a mechanism which can transform cit- 
rulline to arginine so quickly and act upon low concentrations of 
metabolites, less than 0.001 M, is inoperative in viva, teleological as 
the argument is. The quest,ion then arises, what is the source of 
the citrulline? The kidney cannot convert ornithine to citrulline. 
4 It is interesting in retrospect that this interchange of amino nitrogen 
could have been inferred from the fact that ammonia exerts considerable 
nitrogen sparing action even in man. The continual and extensive syn- 
thesis and breakdown of protein was deduced from this and other data (27). 
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If one accepts the ornithine-urea cycle in the liver as proposed by 
Krebs and Henseleit (8), the liver can hardly supply the citrulline, 
because in that cycle the existence of the citrulline is only transitory 
on its way to arginine. 
SUMMARY 
1. Citrulline is converted to arginine at a rapid rate by rat and 
guinea pig surviving kidney slices. This property is almost com- 
pletely lost when the cell structure is destroyed. 
2. Either aspartic acid or glutamic acid is necessary for this re- 
action (in addition to citrulline). 
3. Proline, hydroxyproline, lysine, and ornithine may replace 
the dicarboxylicamino acids in this reaction. Evidence is adduced 
that they do so by being converted first to glutamic acid (or, pos- 
sibly but less likely, to aspartic acid). 
4. Arginine is formed from citrulline and oc-ketoglutaric acid and 
ammonia or oxalacetic acid and ammonia. Evidence is presented 
that these products of oxidative deamination are reduced by kid- 
ney slices to form the parent dicarboxylicamino acids. 
5. This formation of arginine from citrulline is nearly com- 
pletely inhibited by oxidative inhibitors, KCN, AssO+ and AsZ05, 
indicating an oxidative step in the reaction mechanism. The 
cyanide inhibition is relieved in part by t,he cY-keto acid derivative 
of methionine, by oxalacetate, and by pyruvate. The inhibition 
by Asz03 and Asz05 is not relieved by these metabolites. An in- 
terpretation of these findings is presented. 
6. The oxidative step is not a dehydrogenation of the amino 
group of the dicarboxylicamino acid (to form t,he imino group) 
prior to its reaction with citrulline. Evidence is presented that 
this oxidation may be located at a hypothetical intermediate com- 
pound of citrulline and the dicarboxylicamino acid. 
7. Arginine formation from citrulline can be used as an indicator 
of the “preferred” direction of some of the reversible processes in 
the metabolism of the cells. Some examples are presented. 
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